Morgan Stanley Maintains Equal-Weight on Adient, Lowers Price Target to $21
Morgan Stanley analyst Andrew Percoco maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $22 to $21.
Read original at benzingaStocks · News reference
8-K filing — Adient plc (ADNT)
Filed: 2026-08-21 AccNo: 0001670541-26-000100 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Aug 21, 2026, 8:15 PM
- Checked
- Aug 21, 2026, 8:15 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Citigroup Maintains Buy on Adient, Lowers Price Target to $29
Citigroup analyst Michael Ward maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $33 to $29.
Read original at benzingaJP Morgan Maintains Neutral on Adient, Raises Price Target to $28
JP Morgan analyst Rajat Gupta maintains Adient (NYSE:ADNT) with a Neutral and raises the price target from $26 to $28.
Read original at benzinga